A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Jiang, Ning ^a   Zhu, Shimiao ^a   Chen, Jing ^a   Niu, Yuanjie ^a   Zhou, Liqun ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE;

ARTICLE; ASIA; ASIAN; CANCER RISK; CAUCASIAN; ETHNIC DIFFERENCE; EUROPE; HUMAN; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROTEIN EXPRESSION;

HUMANS; MALE; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES;

EID: 84885145971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074386     Document Type: Article

References (38)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer Statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Shin HR, Carlos MC, Varghese C, (2012) Cancer control in the Asia Pacific region: current status and concerns. Jpn J Clin Oncol 42(10): 867-81.
3. Donovan MJ, Cordon-Cardo C, (2013) Predicting high-risk disease using tissue biomarkers. Curr Opin Urol 23(3): 245-5.
4. Humphrey PA, (2007) Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol 60(1): 35-42.
5. Thomson AH, Kulkarni S, Bahl A, (2008) Primary cryotherapy with salvage external beam radiotherapy for locally recurrent prostate cancer. Clin Oncol (R Coll Radiol) 20(5): 385.
6. Kunju LP, Chinnaiyan AM, Shah RB, (2005) Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer. Histopathology 47(6): 587-96.
7. Zhou M, Aydin H, Kanane H, Epstein JI, (2004) How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol 28(2): 239-43.
8. Gupta A, Wang HL, Policarpio-Nicolas ML, Tretiakova MS, Papavero V, et al. (2004) Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol 28(9): 1224-9.
9. Osunkoya AO, Hansel DE, Sun X, Netto GJ, Epstein JI, (2008) Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases. Am J Surg Pathol 32(3): 461-7.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
11. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283: 2008-12.
12. Handoll HH, (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87: 875.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-60.
14. Rogers CG, Yan G, Zha S, Gonzalgo ML, Isaacs WB, et al. (2004) Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein. J Urol 172(4 Pt 1): 1501-3.
15. Shah RB, Tadros Y, Brummell B, Zhou M, (2013) The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers. Hum Pathol M44(5): 786-94.
16. Trpkov K, Bartczak-McKay J, Yilmaz A, (2009) Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens. Am J Clin Pathol 132(2): 211-20.
17. Zhou M, Aydin H, Kanane H, Epstein JI, (2004) How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol 28(2): 239-43.
18. Kaić G, Tomasović-Loncarić C, (2009) Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions. Diagn Cytopathol 37(11): 803-8.
19. Farinola MA, Epstein JI, (2004) Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol 35(10): 1272-8.
20. Puebla-Mora AG, Heras A, Cano-Valdez AM, Domínguez-Malagón H, (2006) Human telomerase and a-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study. Ann Diagn Pathol 10(4): 205-8.
21. Pértega-Gomes N, Vizcaíno JR, Gouveia C, Jerónimo C, Henrique RM, et al. (2013) Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer. Prostate 73(7): 763-9.
22. Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, et al. (2004) Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Hum Pathol 35(12): 1462-8.
23. Nassar A, Amin MB, Sexton DG, Cohen C, (2005) Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer. Appl Immunohistochem Mol Morphol 13(3): 252-5.
24. Jiang Z, Li C, Fischer A, Dresser K, Woda BA, (2005) Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol 123(2): 231-6.
25. Stewart J, Fleshner N, Cole H, Sweet J, (2007) Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study. J Clin Pathol 60(7): 773-80.
26. Yamada H, Tsuzuki T, Maeda N, Yamauchi Y, Yoshida S, et al. (2013) Alpha methylacyl-CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: is AMACR a "race"-dependent marker? Prostate 73(1): 54-9.
27. Chen GY, Liu L, Zhou XG, Zhang CH, Huang SF, (2004) Assessment of P504S immunohistochemistry in diagnosis and differential diagnosis of prostatic adenocarcinoma. Zhonghua Bing Li Xue Za Zhi 33(5): 419-23.
28. Xiao Y, Chen J, Luo YF, Cao JL, Ling Q, et al. (2004) Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas. Zhonghua Yi Xue Za Zhi 84(16): 1362-6.
29. Ng VW, Koh M, Tan SY, Tan PH, (2007) Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Am J Clin Pathol 127(2): 248-53.
30. Yu T, Zhu SX, Zheng S, Chen SP, (2007) Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer. Zhonghua Nan Ke Xue 13(3): 222-5.
31. Zielie PJ, Mobley JA, Ebb RG, Jiang Z, Blute RD, et al. (2004) A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions. J Urol 172(3): 1130-3.
32. Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, et al. (2004) Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology 45(3): 218-25.
33. Kristiansen G, Fritzsche FR, Wassermann K, Jäger C, Tölls A, et al. (2008) GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer 99(6): 939-48.
34. Schostak M, Miller K, Krause H, Schrader M, Kempkensteffen C, et al. (2006) Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions. Cancer Detect Prev 30(5): 449-54.
35. Ouyang B, Bracken B, Burke B, Chung E, Liang J, et al. (2009) A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer. J Urol 181(6): 2508-13.
36. Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, et al. (2002) alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 161(3): 841-8.
37. Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, et al. (2003) Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 63(21): 7365-76.
38. Suzue K, Montag AG, Tretiakova M, Yang XJ, Sahoo S, (2005) Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy. Am J Clin Pathol 123(4): 553-61.